Senator Kamala Harris, who was once seen as a top tier contender for the 2020 Democratic presidential nomination, dropped out of the race on Tuesday.
"I've taken stock and looked at this from every angle, and over the last few days have come to one of the hardest decisions of my life," the California senator wrote in a note to supporters. "My campaign for president simply doesn't have the financial resources we need to continue."
Harris spent the early days of her campaign as a promising candidate, rising as high as second place in the Real Clear Politics poll average in July, but has struggled with finances as well as reports of staff disorganization and infighting, according to the New York Times.
By November, she was polling in the low single digits and laid off her New Hampshire field team to increase her focus on Iowa's first-in-the-nation caucuses on February 3.
Though she had shifted focus to the Hawkeye State, she lacked the cash to run TV ads in Iowa, a state in which Harris had not run an ad in three months. Only recently, support for a super PAC made up of former aides to pay for advertising began to gain traction within the campaign.
Harris was one of seven candidates who had already qualified for the sixth debate, which will be held in her home state of California, before today's announcement.
The senator had started her campaign in front of a crowd of20,000 in Oakland, according to her campaign, and said she is withdrawing "with deep regret — but also with deep gratitude."
President Joe Biden says the U.S. expects to take delivery of enough coronavirus vaccines for all adult Americans by the end of May, two months earlier than anticipated.
State Representative Marcus C. Evans, Jr. from Chicago filed amendments to an Illinois bill that would further ban games considered to be too violent from reaching the hands of minors.
Texas is lifting a COVID-19 mask mandate that was imposed last summer but has only been lightly enforced. Republican Gov. Greg Abbott’s announcement Tuesday makes Texas the largest state to do away with a face covering order.
Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly.
Calls for New York Gov. Andrew Cuomo to resign are intensifying now that a third woman has accused him of offensive behavior.
The pill comprises 40% of the profits in the U.S. contraceptive market and 25% of contraceptive consumers, causing millions of unnecessary ‘periods’ along the way. So, why hasn’t birth control evolved beyond the pseudo-period?
This is your Washington Week Ahead for the week of March 1.
U.S. health advisers have endorsed a one-dose COVID-19 vaccine from Johnson & Johnson that's expected to provide an easier-to-use option to fight the pandemic.
Following the Senate Intelligence Committee hearing on the widespread SolarWinds cyberattack, cybersecurity experts are pushing the need for private businesses and federal agencies to cooperate closely to prevent future such breaches.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
